A BMJ Medicine review of 29 randomised controlled trials found small short term mental health and quality of life gains for multimorbidity involving depression or anxiety, with collaborative care showing the clearest sustained benefit.
A BMJ Medicine review of 29 randomised controlled trials found small short term mental health and quality of life gains for multimorbidity involving depression or anxiety, with collaborative care showing the clearest sustained benefit.
A BMJ Medicine systematic review of 140 randomised trials suggests that provider education combined with audit and feedback can help reduce low-value care in primary care.
A BMJ Medicine cohort study suggests HRT prescribing in UK primary care varies by ethnicity, deprivation, and region, raising important questions about equitable access to menopause care.
A BJGP Open study suggests relational continuity in English general practice is stronger for some groups, including older adults with polypharmacy and patients more likely to see a preferred GP.
When Benjamin Franklin asked his contacts in France to send over a mysterious elixir for his gout in the 1760s, he probably did not realise he was ordering a medicine that had already been known, mainly as a poison, for more than a millennium. The concoction, sold as Eau Medicinale by French officer Nicolas Husson, […]
Heart disease remains the leading cause of death globally. Despite advancements in understanding risk factors like high cholesterol and blood pressure, a groundbreaking discovery from Spanish researchers at the National Center for Cardiovascular Research (CNIC) in Madrid has unveiled an unexpected villain: your gut bacteria. Fifteen years ago, researchers set out to study thousands of […]
Breaking the Cycle of Recurrent UTIs: An Innovative Non-Antibiotic Approach Recurrent urinary tract infections (rUTIs) are among the most common and frustrating clinical conditions faced by healthcare professionals. Not only do they impair patients’ quality of life, but they also significantly contribute to antibiotic resistance—a growing global health crisis. A recent groundbreaking study published in […]
CHOL001 and CHOL002 are no longer in the Quality and Outcomes Framework. From April 2024 they were replaced by CHOL003 and CHOL004, and for 2025/26 these two indicators became some of the highest-point earners in the entire QOF. Between them they now carry 82 points, more than any other clinical area in the framework. This […]
A Fresh Look at an Old Ally: Mirtazapine for Insomnia in the Older Adult (7.5mg superior than 15mg) https://doi.org/10.1093/ageing/afaf050 1. Why This Conversation Won’t Go Away Anyone running a geriatric clinic knows the nightly battle cry: “Doctor, I just can’t sleep.” Benzodiazepines and so-called “Z-drugs” remain common fixes, yet both families bring cognitive haze, falls, […]
Anastrozole’s repurposing as a preventive treatment marks a significant advancement in breast cancer care. This post examines Anastrozole’s action, effectiveness, side effects, dosage, UK cost, and eligibility criteria. Mechanism of Action Anastrozole is an aromatase inhibitor. It works by blocking aromatase, reducing estrogen production. Since some breast cancers are estrogen-dependent, lowering estrogen levels can prevent […]